![Barbara Leyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Leyman
No open positions remaining
Net worth: 46 943 $ as of 31/05/2026
Profile
Barbara Leyman worked as Senior Investment Manager at Limburgse Reconversie Maatschappij NV from 2014 to 2017.
Former jobs include Non-Executive Director at Apitope International NV, Director at Amakem NV, Director at Complix NV, Chief Business Development Officer at Sutro Biopharma, Inc. from 2024 to 2025, and Senior Vice President-Corporate Development at Breeze Bio, Inc. Education includes a doctorate from Imperial College London and a graduate degree from Ghent University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/07/2025 | 1,606 ( 0.01% ) | 46 943 $ | 31/05/2026 |
Former positions of Barbara Leyman
| Companies | Position | End |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01/12/2025 |
Limburgse Reconversie Maatschappij NV
 Limburgse Reconversie Maatschappij NV Investment ManagersFinance LRM invests in companies located in Belgium. The firm targets companies operating in broad range of sectors and industries. It provides financing for seed, early, growth and mezzanine transactions. | Private Equity Investor | 01/07/2017 |
GenEdit, Inc.
 GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Corporate Officer/Principal | - |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Director/Board Member | - |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Director/Board Member | - |
Training of Barbara Leyman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limburgse Reconversie Maatschappij NV
Limburgse Reconversie Maatschappij NV Investment ManagersFinance LRM invests in companies located in Belgium. The firm targets companies operating in broad range of sectors and industries. It provides financing for seed, early, growth and mezzanine transactions. | Finance |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Health Technology |
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
- Stock Market
- Insiders
- Barbara Leyman
Choose MarketScreener 
